Lazaros Belbasis

Lazaros Belbasis

Auto-generated profile, based on publicly available information

Lazaros Belbasis

Nuffield Department of Population Health, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in The Lancet Neurology
Verified
Journal Article
Closed access
LBLazaros Belbasis
Lazaros Belbasis
VBVanesa Bellou
Vanesa Bellou
EEEvangelos Evangelou
Evangelos Evangelou
JIJohn P A Ioannidis
John P A Ioannidis
ITIoanna Tzoulaki
Ioanna Tzoulaki

20 March 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VBVanesa Bellou
Vanesa Bellou
LBLazaros Belbasis
Lazaros Belbasis
ITIoanna Tzoulaki
Ioanna Tzoulaki
EEEvangelos Evangelou
Evangelos Evangelou
Type 2 diabetes mellitus (T2DM) is a global epidemic associated with increased health expenditure, and low quality of life. Many non-genetic risk factors have been suggested, but their overall epidemiological credibility has not been assessed. We searched PubMed to capture all meta-analyses and Mendelian randomization studies for risk factors of T2DM. For each association, we estimated the summary effect size, its 95% confidence and prediction interval, and the I2 metric. We examined the presence of small-study effects and excess significance bias. We assessed the epidemiological credibility through a set of predefined criteria. We captured 86 eligible papers (142 associations) covering a wide range of biomarkers, medical conditions, and dietary, lifestyle, environmental and psychosocial factors. Adiposity, low hip circumference, serum biomarkers (increased level of alanine aminotransferase, gamma-glutamyl transferase, uric acid and C-reactive protein, and decreased level of adiponectin and vitamin D), an unhealthy dietary pattern (increased consumption of processed meat and sugar-sweetened beverages, decreased intake of whole grains, coffee and heme iron, and low adherence to a healthy dietary pattern), low level of education and conscientiousness, decreased physical activity, high sedentary time and duration of television watching, low alcohol drinking, smoking, air pollution, and some medical conditions (high systolic blood pressure, late menarche age, gestational diabetes, metabolic syndrome, preterm birth) presented robust evidence for increased risk of T2DM. A healthy lifestyle pattern could lead to decreased risk for T2DM. Future randomized clinical trials should focus on identifying efficient strategies to modify harmful daily habits and predisposing dietary patterns.

1 February 2016 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
VBVanesa Bellou
Vanesa Bellou
LBLazaros Belbasis
Lazaros Belbasis
ITIoanna Tzoulaki
Ioanna Tzoulaki
EEEvangelos Evangelou
Evangelos Evangelou
JIJohn P.A. Ioannidis
John P.A. Ioannidis

22 November 2022 in BMJ Medicine
Verified
Journal Article
Open access
PDF file
LBLazaros Belbasis
Lazaros Belbasis
VBVanesa Bellou
Vanesa Bellou
JIJohn P A Ioannidis
John P A Ioannidis
In this article, Lazaros Belbasis and colleagues explain the rationale for umbrella reviews and the key steps involved in conducting an umbrella review, using a working example.

3 September 2016 in Alzheimer's & Dementia
Verified
Journal Article
Open access
VBVanesa Bellou
Vanesa Bellou
LBLazaros Belbasis
Lazaros Belbasis
ITIoanna Tzoulaki
Ioanna Tzoulaki
Lefkos MiddletonLefkos Middleton
Lefkos Middleton
JIJohn P.A. Ioannidis
John P.A. Ioannidis
EEEvangelos Evangelou
Evangelos Evangelou
Introduction: Dementia is a heterogeneous neurodegenerative disease, whose etiology results from a complex interplay between environmental and genetic factors.Methods: We searched PubMed to identify meta‐analyses of observational studies that examined associations between nongenetic factors and dementia. We estimated the summary effect size using random‐effects and fixed‐effects model, the 95% CI, and the 95% prediction interval. We assessed the between‐study heterogeneity (I‐square), evidence of small‐study effects, and excess significance.Results: A total of 76 unique associations were examined. By applying standardized criteria, seven associations presented convincing evidence. These associations pertained to benzodiazepines use, depression at any age, late‐life depression, and frequency of social contacts for all types of dementia; late‐life depression for Alzheimer's disease; and type 2 diabetes mellitus for vascular dementia and Alzheimer's disease.Discussion: Several risk factors present substantial evidence for association with dementia and should be assessed as potential targets for interventions, but these associations may not necessarily be causal.

28 September 2016 in BMC Medicine
Verified
Journal Article
Open access
PDF file
LBLazaros Belbasis
Lazaros Belbasis
MSMakrina D. Savvidou
Makrina D. Savvidou
CKChidimma Kanu
Chidimma Kanu
EEEvangelos Evangelou
Evangelos Evangelou
ITIoanna Tzoulaki
Ioanna Tzoulaki
Birth weight, a marker of the intrauterine environment, has been extensively studied in epidemiological research in relation to subsequent health and disease. Although numerous meta-analyses have been published examining the association between birth weight and subsequent health-related outcomes, the epidemiological credibility of these associations has not been thoroughly assessed. The objective of this study is to map the diverse health outcomes associated with birth weight and evaluate the credibility and presence of biases in the reported associations. An umbrella review was performed to identify systematic reviews and meta-analyses of observational studies investigating the association between birth weight and subsequent health outcomes and traits. For each association, we estimated the summary effect size by random-effects and fixed-effects models, the 95 % confidence interval, and the 95 % prediction interval. We also assessed the between-study heterogeneity, evidence for small-study effects and excess significance bias. We further applied standardized methodological criteria to evaluate the epidemiological credibility of the statistically significant associations. Thirty-nine articles including 78 associations between birth weight and diverse outcomes met the eligibility criteria. A wide range of health outcomes has been studied, ranging from anthropometry and metabolic diseases, cardiovascular diseases and cardiovascular risk factors, various cancers, respiratory diseases and allergies, musculoskeletal traits and perinatal outcomes. Forty-seven of 78 associations presented a nominally significant summary effect and 21 associations remained statistically significant at P < 1 × 10−6. Thirty associations presented large or very large between-study heterogeneity. Evidence for small-study effects and excess significance bias was present in 13 and 16 associations, respectively. One association with low birth weight (increased risk for all-cause mortality), two dose-response associations with birth weight (higher bone mineral concentration in hip and lower risk for mortality from cardiovascular diseases per 1 kg increase in birth weight) and one association with small-for-gestational age infants with normal birth weight (increased risk for childhood stunting) presented convincing evidence. Eleven additional associations had highly suggestive evidence. The range of outcomes convincingly associated with birth weight might be narrower than originally described under the “fetal origin hypothesis” of disease. There is weak evidence that birth weight constitutes an effective public health intervention marker.